Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Acute Renal Failure
32%
Attenuation
64%
Cardiomyopathy
37%
Combined Evaluation
24%
Computed Tomography
32%
Contrast Dose
56%
Coronary CT Angiography
56%
Counseling Quality
32%
Disease-associated
32%
Dissociation
32%
Echocardiographic
32%
Echocardiographic Speckle Tracking
32%
Effusion
32%
Ejection Fraction
37%
Geometric Assessment
32%
Hospital Performance
32%
Iodinated Contrast
24%
Left Ventricular Function
64%
Left Ventricular Remodeling
32%
Low-dose Radiation
32%
Mechanistic Characterization
32%
Mechanistic Insights
32%
Mitral Annular Displacement
32%
Mitral Valve
32%
Multidetector Computed Tomography
64%
Myocardial Infarction
64%
Myocardial Perfusion
67%
Myocardial Segment
24%
Parametric Maps
32%
Pemetrexed
32%
Perfusion Abnormality
64%
Quality Metrics
32%
Radiation Exposure
24%
Rapid Estimation
32%
Reduced Radiation Dose
32%
Regadenoson
64%
Risk Factor Management
32%
Shape Analysis
32%
Sickle Cell Disease
32%
Significant Stenosis
24%
Smoking Cessation Counseling
32%
Stenosis
32%
Stress Testing
24%
Stress-induced
24%
Three-dimensional (3D)
60%
Three-dimensional Echocardiography
37%
Tube Voltage
48%
Ultra-low
32%
Vasodilator Stress
32%
X-ray Attenuation
24%
Medicine and Dentistry
Acute Heart Infarction
24%
Angina pectoris
16%
Bleeding
16%
Cardiac Magnetic Resonance Imaging
57%
Clinician
21%
Computed Tomography Angiography
32%
Computer Assisted Tomography
32%
Consent Process
16%
Coronary Angiography
64%
Coronary Artery
21%
Coronary Artery Obstruction
26%
Diastolic Dysfunction
56%
Diastolic Function
32%
Dilated Cardiomyopathy
16%
Echocardiography
57%
Ejection Fraction
100%
Gadolinium
19%
Heart Left Ventricle Ejection Fraction
18%
Heart Left Ventricle Function
78%
Heart Muscle Perfusion
77%
Heart Ventricle Remodeling
32%
Informed Consent
32%
Iodine
26%
Iron Overload
19%
Left Ventricle
22%
microRNA
19%
Mitral Valve
32%
Multidetector Computed Tomography
64%
Myocardial Disease
40%
Myocardial Infarction
32%
Myocardium
26%
Outpatient
16%
Patient Decision Making
32%
Patient with Sickle Cell Disease
77%
Percutaneous Coronary Intervention
24%
Quality Improvement
32%
Radiation Exposure
26%
Regadenoson
64%
Reproducibility
32%
Right Ventricular Function
32%
Shared Decision Making
16%
Sickle-Cell Disease
91%
Speckle Tracking Echocardiography
38%
Stenosis
64%
Systolic Function
21%
Three Dimensional Echocardiography
40%
Three Dimensional Speckle Tracking Echocardiography
64%
Treatment Group
16%
Tricuspid Insufficiency
32%
Two Dimensional Echocardiography
18%